Edition:
United Kingdom

Sinovac Biotech Ltd (SVA.OQ)

SVA.OQ on NASDAQ Stock Exchange Global Select Market

7.61USD
17 Jul 2018
Change (% chg)

$-0.17 (-2.19%)
Prev Close
$7.78
Open
$7.82
Day's High
$7.82
Day's Low
$7.60
Volume
2,430
Avg. Vol
13,034
52-wk High
$8.75
52-wk Low
$6.50

Chart for

About

Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1)... (more)
No analyst recommendations are available for .

Overall

Beta: 0.08
Market Cap(Mil.): $399.48
Shares Outstanding(Mil.): 56.91
Dividend: --
Yield (%): --

Financials

  SVA.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.11 -- --
ROI: -6.06 15.07 14.61
ROE: -5.15 16.60 16.34

BRIEF-Sinovac Amends Shareholder Rights Plan

* SINOVAC BIOTECH LTD - ‍AMENDMENT EXTENDS EXPIRATION OF SHAREHOLDER RIGHTS PLAN FROM MARCH 27 TO MARCH 27, 2019​ Source text for Eikon: Further company coverage:

06 Mar 2018

BRIEF-Sinovac Provides Update On Going Private Transaction

* SINOVAC BIOTECH - EXPECTS TO FILE AMENDED GOING-PRIVATE STATEMENT, INCLUDING A DEFINITIVE PROXY STATEMENT AS AN EXHIBIT, WITH U.S. SEC IN DUE COURSE Source text for Eikon: Further company coverage:

07 Feb 2018

Competitors

Earnings vs. Estimates